{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:52:00Z","timestamp":1781844720931,"version":"3.54.5"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Background: Age at diagnosis and histologic differentiation are clinically relevant in early gastric cancer (GC), as poorly differentiated tumors and those diagnosed in younger patients often demonstrate more aggressive characteristics. Serum microRNAs (miRNAs) may provide insights into the molecular basis of these features. Methods: We compared expression profiles between undifferentiated and differentiated early GC cases to identify differentially expressed miRNAs (DEmiRNAs) and associated enriched pathways. Using Lasso regression, we developed and cross-validated a histologic differentiation classifier based on miRNA profiles from 1399 early GC serum samples. Finally, cancer-specific miRNA differences between adolescent and young adult (AYA) and non-AYA patients were evaluated using samples from cancer cases and normal controls. Results: We identified 75 differentiation-associated DEmiRNAs targeting genes enriched in cancer hallmark pathways such as TP53 and PI3K\/AKT\/mTOR signaling. In the validation set, the combined Lasso model predicted differentiation status with a sensitivity of 69.2%, specificity of 75.3%, positive predictive value (PPV) of 66.9%, negative predictive value (NPV) of 77.2%, an overall accuracy of 73.1%, and an area under the curve (AUC) of 79.7%. Comparison of AYA and non-AYA groups identified 52 cancer-specific and age-related miRNAs. Notably, three components of a previously reported four-miRNA GC diagnostic signature were significantly associated with age. Conclusions: Age-related variation in miRNA expression suggests that patient age may influence the performance of the existing four-miRNA diagnostic signature in early GC. Overall, our findings demonstrate the utility of miRNA profiling for predicting differentiation status in early GC and reveal age-associated variation in cancer-specific miRNAs.<\/jats:p>","DOI":"10.3390\/biom16060869","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:49:42Z","timestamp":1781743782000},"page":"869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum microRNA Profiles Reflect Differentiation Status and Age in Early Gastric Cancer"],"prefix":"10.3390","volume":"16","author":[{"given":"Marwa","family":"Shekfeh","sequence":"first","affiliation":[{"name":"Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1708-1348","authenticated-orcid":false,"given":"Mariam M.","family":"Konat\u00e9","sequence":"additional","affiliation":[{"name":"Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Sankaran","sequence":"additional","affiliation":[{"name":"Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7053-5652","authenticated-orcid":false,"given":"Ming-Chung","family":"Li","sequence":"additional","affiliation":[{"name":"Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djx262","article-title":"The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites","volume":"110","author":"Anderson","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/gutjnl-2019-319631","article-title":"Early gastric cancer detection in high-risk patients: A multicentre randomised controlled trial on the effect of second-generation narrow band imaging","volume":"70","author":"Yoshida","year":"2021","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41571-023-00767-w","article-title":"Early stage gastric adenocarcinoma: Clinical and molecular landscapes","volume":"20","author":"Hirata","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9638041","DOI":"10.1155\/2016\/9638041","article-title":"Early Gastric Cancer: Current Advances of Endoscopic Diagnosis and Treatment","volume":"2016","author":"Zhu","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/jnci\/djae162","article-title":"Personalized starting age of gastric cancer screening based on individuals\u2019 risk profiles: A population-based, prospective study","volume":"116","author":"He","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/jama.2025.10218","article-title":"Early-Onset Gastrointestinal Cancers: A Review","volume":"334","author":"Jayakrishnan","year":"2025","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9512707","DOI":"10.1155\/2020\/9512707","article-title":"Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis","volume":"2020","author":"Li","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.3748\/wjg.v20.i19.5694","article-title":"Role of microRNAs in gastric cancer","volume":"20","author":"Ishiguro","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009734.2012.659294","article-title":"Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors","volume":"117","author":"Jogi","year":"2012","journal-title":"Upsala J. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: The future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3748\/wjg.v24.i30.3313","article-title":"MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives","volume":"24","author":"Link","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Licursi, V., Conte, F., Fiscon, G., and Paci, P. (2019). MIENTURNET: An interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinform., 20.","DOI":"10.1186\/s12859-019-3105-x"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10120-021-01161-0","article-title":"A novel combination of serum microRNAs for the detection of early gastric cancer","volume":"24","author":"Abe","year":"2021","journal-title":"Gastric Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e4262","DOI":"10.7717\/peerj.4262","article-title":"RBiomirGS: An all-in-one miRNA gene set analysis solution featuring target mRNA mapping and expression profile integration","volume":"6","author":"Zhang","year":"2018","journal-title":"PeerJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the Lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J. R. Stat. Soc. B"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"W180","DOI":"10.1093\/nar\/gky509","article-title":"TAM 2.0: Tool for MicroRNA set analysis","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1515\/med-2021-0347","article-title":"The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis","volume":"16","author":"Guo","year":"2021","journal-title":"Open Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2013.12.025","article-title":"miR-92a family and their target genes in tumorigenesis and metastasis","volume":"323","author":"Li","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","article-title":"MicroRNAs: Novel regulators in the hallmarks of human cancer","volume":"285","author":"Ruan","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13046-020-01767-9","article-title":"The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1","volume":"40","author":"Xu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.biopha.2017.11.090","article-title":"MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14","volume":"96","author":"Du","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1010428317697565","DOI":"10.1177\/1010428317697565","article-title":"MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A","volume":"39","author":"Quan","year":"2017","journal-title":"Tumour Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1373\/clinchem.2018.295824","article-title":"MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer","volume":"65","author":"Matin","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-024-02084-x","article-title":"The role of microRNAs in the gastric cancer tumor microenvironment","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_29","first-page":"395","article-title":"The p53\/microRNA connection in gastrointestinal cancer","volume":"7","author":"Rokavec","year":"2014","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/biosci\/biu133","article-title":"p53: The Barrier or Guardian for Cell Dedifferentiation?","volume":"64","author":"Yu","year":"2014","journal-title":"Bioscience"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20302","DOI":"10.18632\/aging.203412","article-title":"Regulation of follistatin-like 3 expression by miR-486-5p modulates gastric cancer cell proliferation, migration and tumor progression","volume":"13","author":"Dai","year":"2021","journal-title":"Aging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.18632\/oncotarget.7417","article-title":"miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","first-page":"6511","article-title":"MiRNA-210: A Current Overview","volume":"37","author":"Bavelloni","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.3390\/ijms16036353","article-title":"The role of hypoxia-induced miR-210 in cancer progression","volume":"16","author":"Dang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fncel.2017.00285","article-title":"MicroRNA-210 Protects PC-12 Cells Against Hypoxia-Induced Injury by Targeting BNIP3","volume":"11","author":"Luan","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wei, C.Z., Li, Y.T., Lin, Z.H., Lin, F.Z., Chen, X.J., Nie, R.C., Chen, G.M., Xue, Z.C., and Zheng, Z.Q. (2026). Cellular senescence in gastric cancer: A novel prognostic stratification and immune predictor. BMC Med. Genom., 19.","DOI":"10.1186\/s12920-026-02346-1"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41419-020-2270-1","article-title":"miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2023.04.055","article-title":"miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K\/AKT\/mTOR signaling","volume":"662","author":"Bi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","first-page":"1505","article-title":"miR-92b promotes autophagy and suppresses viability and invasion in breast cancer by targeting EZH2","volume":"53","author":"Liu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zhao, F., Yang, Z., Gu, X., Feng, L., Xu, M., and Zhang, X. (2021). miR-92b-3p Regulates Cell Cycle and Apoptosis by Targeting CDKN1C, Thereby Affecting the Sensitivity of Colorectal Cancer Cells to Chemotherapeutic Drugs. Cancers, 13.","DOI":"10.3390\/cancers13133323"},{"key":"ref_41","first-page":"11","article-title":"The endoscopic diagnosis of early gastric cancer","volume":"26","author":"Yao","year":"2013","journal-title":"Ann. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gie.2021.06.033","article-title":"Deep learning system compared with expert endoscopists in predicting early gastric cancer and its invasion depth and differentiation status (with videos)","volume":"95","author":"Wu","year":"2022","journal-title":"Gastrointest. Endosc."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Feng, F., Liu, J., Wang, F., Zheng, G., Wang, Q., Liu, S., Xu, G., Guo, M., Lian, X., and Zhang, H. (2018). Prognostic value of differentiation status in gastric cancer. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4780-0"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N. Engl. J. Med."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:15:14Z","timestamp":1781842514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["biom16060869"],"URL":"https:\/\/doi.org\/10.3390\/biom16060869","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]}}}